RxSight (RXST) Share-based Compensation Growth (3y) (2023 - 2026)
RxSight (RXST) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | - |
| 10 | RxSight | 226.56 Mn | -191.64 Mn | 23.50 Mn | 86.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.57% |
| Dec 31, 2025 | -62.69% |
| Sep 30, 2025 | 112.31% |
| Jun 30, 2025 | 134.95% |
| Mar 31, 2025 | 334.57% |
| Dec 31, 2024 | 35.66% |
| Sep 30, 2024 | 209.03% |
| Jun 30, 2024 | 223.70% |
| Mar 31, 2024 | 55.91% |
| Dec 31, 2023 | 706.51% |
| Sep 30, 2023 | -10.82% |
| Jun 30, 2023 | -6.68% |